Jubilant Life Sciences inks long-term supply pact with global firm

17 Aug 2011 Evaluate

Jubilant Life Sciences, an integrated pharmaceutical industry player and the largest Custom Research and Manufacturing Services Company in India, has signed a long term supply agreement in Proprietary Products business with a leading international Life Sciences company.

The total contract is valued at over $80 million to be supplied in three years from the quarter April-June 2012. This contract has a minimum volume 'take or pay' commitment and has an opportunity to go over $100 million.

This product has a huge demand in the market which is vindicated by the release of advance payment by the customer on the signing of the contract. Further, the company said that it continues to see strong growth in the proprietary products segment and expects to sign a few more contracts during the year.

At present, the company provides life sciences products and services across different sectors. The company’s consolidated net profit rose 52.92% to Rs 77.12 crore for the first quarter ended June 30, 2011, against Rs 50.43 crore in the same period previous fiscal. Total income rose to Rs 948.48 crore for the quarter ended June 30, 2011 up by 15.86% compared with Rs 818.61 crore in the same period previous financial year.

Jubilant Pharmova Share Price

1073.50 4.30 (0.40%)
05-Dec-2025 15:55 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1805.00
Dr. Reddys Lab 1276.55
Cipla 1520.55
Zydus Lifesciences 933.10
Lupin 2097.65
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×